Exposure to certain ‘forever chemicals’ could heighten risk of aggressive breast cancer, NIH says - The Boston Globe

A new NIH study suggests a correlation between high levels of 'forever chemicals' (PFAS) in the blood and an increased risk of aggressive, estrogen receptor-negative breast cancer. Researchers emphasize that these findings show correlation rather than direct causation.
Why it matters
PFAS chemicals are ubiquitous in consumer products, making the potential health risks a significant concern for public health policy and environmental regulation.
Women with high levels of two common “forever chemicals” in their blood may face a higher risk of developing an aggressive form of breast cancer, according to new research from the National Institutes of Health .
The study, published last week in the Journal of Clinical Oncology , found that women with the highest levels of two chemicals known as PFOA and PFOS faced higher rates of estrogen receptor-negative breast cancer, a form of the disease that tends to be more aggressive and harder to treat.
Women with the highest levels of PFOA had a 67 percent higher rate of this type of breast cancer, compared with woman who had the lowest levels. For PFOS, the rate was 93 percent higher, according to NIH.
Researchers found “no clear association” between the two chemicals and breast cancer overall, according to NIH.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in